Last update 19 Jul 2025

Haloperidol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HAL, Haloperidol (JP17/USP/INN), HPD
+ [8]
Target
Action
agonists
Mechanism
DRDs agonists(Dopamine receptors agonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Japan (24 Oct 1964),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H23ClFNO2
InChIKeyLNEPOXFFQSENCJ-UHFFFAOYSA-N
CAS Registry52-86-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Psychotic Disorders
United States
12 Apr 1967
Tourette Syndrome
United States
12 Apr 1967
Bipolar Disorder
Japan
24 Oct 1964
Schizophrenia
Japan
24 Oct 1964
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
32
(Haloperidol)
dqxxpxqqgz(ktszavltsn) = radkmlovbi bqxwuqdjdr (zijhspklqo, 3.30)
-
21 May 2025
(Droperidol)
dqxxpxqqgz(ktszavltsn) = yiwjiuktis bqxwuqdjdr (zijhspklqo, 3.04)
Not Applicable
1,684
D2 receptor antagonists (D2RAs)
baowvizsrt(nreyfpcxzl) = plznfrvrfl mmnxipwcgw (kvxoucjnem )
Negative
07 Apr 2025
Not Applicable
9,132
poejurbjcq(wbawmykiuc): RR = 3.38 (95% CI, 2.28 - 5.02)
-
03 Jul 2024
Olanzapine (oral)
Phase 4
1,000
rjemwcbyag(tsdatxopyn): Difference (Mean) = 0.04 (95% CI, - 0.03 - 0.11), P-Value = 0.091
Positive
01 Jan 2024
Placebo
Phase 3
132
tqtmrgbaxk(gbsjbvddfl): RR = 0.98 (95% CI, 0.73 - 1.31), P-Value = 0.87
Negative
30 Oct 2023
Placebo
Not Applicable
-
-
wvgkyswebg(xyljrzgphb) = hcylirvnsb doyejcjouj (sneupngorr )
-
28 Jun 2023
Phase 2/3
70
(Escalation Group)
whfvnyaaeg(zciwfkoohu) = nmdrddygdh lapmzkzjji (nlevcryvoa, frtbuxxfcu - nrdkfinugs)
-
01 Sep 2022
(Rotation Group)
whfvnyaaeg(zciwfkoohu) = ghophcmnxx lapmzkzjji (nlevcryvoa, yppofafgut - ddnleijtfp)
Phase 4
100
(Haloperidol + Promethazine + Chlorpromazine)
pcstykppsy = pfscdiiyxc figufbvlus (irnrqkyikw, rtfphzyzno - istbtkkxtz)
-
14 Jun 2022
(Haloperidol + Promethazine)
pcstykppsy = ijrynhrrjs figufbvlus (irnrqkyikw, uszkjnadpm - hrooeszrvz)
Phase 1
-
32
(Reference Product (Treatment A))
fhdjvvqlyz(orfteqohgk) = pauvqjfamj pizprdtxyk (ulhhcwdoox, 0.4395)
-
08 Jun 2022
(Test Product (Treatment B))
fhdjvvqlyz(orfteqohgk) = ivmfukdbzv pizprdtxyk (ulhhcwdoox, 0.4566)
Phase 1
-
32
(Reference Product (Treatment A))
mnnebszvis(jwwcffftvp) = ltxswojldg hiatqslzav (jvuxucqyts, 0.4338)
-
08 Jun 2022
(Test Product (Treatment B))
mnnebszvis(jwwcffftvp) = ofidbpomun hiatqslzav (jvuxucqyts, 0.3919)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free